[2023 ESC Guidelines for the management of acute coronary syndromes]
G Ital Cardiol (Rome)
.
2024 Feb;25(2 Suppl 2):e1-e112.
doi: 10.1714/4191.41785.
[Article in Italian]
Authors
Robert A Byrne
,
Xavier Rossello
,
J J Coughlan
,
Emanuele Barbato
,
Colin Berry
,
Alaide Chieffo
,
Marc J Claeys
,
Gheorghe-Andrei Dan
,
Marc R Dweck
,
Mary Galbraith
,
Martine Gilard
,
Lynne Hinterbuchner
,
Ewa A Jankowska
,
Peter Jüni
,
Takeshi Kimura
,
Vijay Kunadian
,
Margret Leosdottir
,
Roberto Lorusso
,
Roberto F E Pedretti
,
Angelos G Rigopoulos
,
Maria Rubini Gimenez
,
Holger Thiele
,
Pascal Vranckx
,
Sven Wassmann
,
Nanette Kass Wenger
,
Borja Ibanez
;
ESC Scientific Document Group
PMID:
38291910
DOI:
10.1714/4191.41785
No abstract available
MeSH terms
Acute Coronary Syndrome* / therapy
Humans
Platelet Aggregation Inhibitors / therapeutic use
Risk Assessment
Substances
Platelet Aggregation Inhibitors